Log in or Sign up for Free to view tailored content for your specialty!
Bone/Mineral Metabolism News
Osteoporosis therapies reduce fracture risk for women regardless of BMD status

Osteoporosis therapies work equally well for women at high risk for fracture with high or low bone mineral density, according to data from the virtual American Society for Bone and Mineral Research Annual Meeting.
Palovarotene ‘potential’ therapeutic option for rare, disabling bone disease

Palovarotene reduced new heterotopic ossification volume in children and adults with fibrodysplasia ossificans progressiva, according to data from a phase 3 trial.
Log in or Sign up for Free to view tailored content for your specialty!
Burosumab effects persist long-term for children with rare form of rickets

Treatment with the monoclonal antibody burosumab led to normalized serum phosphorus levels and improvements in rickets severity and lower-limb deformity among young children with X-linked hypophosphatemia, according to a speaker.
Zoledronic acid maintains BMD gains after overlapping teriparatide, denosumab treatment

A single dose of zoledronic acid effectively maintains large and rapid gains in spine and hip bone mineral density after 15 months of overlapping teriparatide and denosumab therapy, according to a speaker.
Bone, muscle strength decreased among children with type 1 diabetes

Youths with type 1 diabetes have weaker bone and lower muscle strength than their healthy peers, according to a presenter at the American Society for Bone and Mineral Research virtual meeting.
Prolonged effects from osteoporotic fractures drive health care, indirect costs

Women who sustain any type of osteoporotic fracture have higher adjusted all-cause health care costs and indirect costs in the 5 years after fracture compared with matched nonfracture controls, according to a speaker.
Zoledronic acid modestly increases atrial fibrillation risk vs. denosumab

Adults with osteoporosis prescribed zoledronic acid have an increased risk for atrial fibrillation when compared with denosumab, according to a study data.
Bioavailable, free and total 25-(OH)D provide similar results in assessing bone health

There is minimal difference among bioavailable, free and total serum 25-hydroxyvitamin D for predicting bone health in older adults, according to data presented at the American Society for Bone and Mineral Research virtual meeting.
Circadian rhythm disruption may accelerate aging, drive cardiometabolic disease

Sleep-wake circadian rhythm is an important mechanism to maintain biological timekeeping, and disruptions from light exposure, dietary challenges and timing of food intake can have cardiometabolic consequences, according to a speaker.
Urinary calcium excretion linked to bone accrual for youths with type 1 diabetes

Compared with healthy peers, a cohort of children and teens with type 1 diabetes accrued less bone over 12 months, particularly those with high urinary calcium excretion, making them more susceptible to fractures, according to study data.
-
Headline News
Limiting daily TV time to 1 hour may reduce risk for atherosclerotic heart disease
March 12, 20253 min read -
Headline News
King Holmes, ‘giant’ of medicine and STI research, dies at 87
March 11, 20252 min read -
Headline News
Pregnancy may bring about persistent changes to the eye
March 10, 20252 min read
-
Headline News
Limiting daily TV time to 1 hour may reduce risk for atherosclerotic heart disease
March 12, 20253 min read -
Headline News
King Holmes, ‘giant’ of medicine and STI research, dies at 87
March 11, 20252 min read -
Headline News
Pregnancy may bring about persistent changes to the eye
March 10, 20252 min read